Cuorips (4894) Fundamentals 2026 — Revenue Analysis | SniperIQ
Cuorips (4894) is a JP-listed Healthcare company in Biotechnology with a market capitalization of ¥34.6B, trading at ¥4185.00 on the JPX. This SniperIQ fundamentals page covers Cuorips's valuation, profitability (net margin -481.6%), revenue (¥212M in FY2025), balance-sheet quality, and AI signal context — from live market data, research only.
Full research coverage
- 8-Quarter Revenue & Margin Trend
- Debt Maturity & Coverage
- Peer Valuation Comparison
- Free Cash Flow & Owner Earnings
- AI Signal + Institutional Flow
- DCF Valuation Model
Frequently Asked Questions
What is Cuorips's market cap?
Cuorips (4894) has a market capitalization of approximately ¥34.6B, trading at ¥4185.00 on the JPX. Market cap moves with the live share price.
What is Cuorips's P/E ratio?
Cuorips's trailing twelve-month P/E ratio is not meaningful (negative or nil earnings), with a price-to-book (P/B) of 7.3x. Valuation multiples are best compared with Healthcare sector peers rather than read in isolation.
How profitable is Cuorips?
Cuorips runs a net profit margin of -481.6%, a gross margin of 21.6%, and an operating margin of -509.2%. Margins and ROE indicate how efficiently the business converts sales into profit and shareholder returns.
How much revenue does Cuorips generate?
Cuorips reported revenue of ¥212M for fiscal year 2025, with net income of -¥1.0B and earnings per share (EPS) of -124.55. SniperIQ tracks the full 8-quarter revenue and margin trend on the research dashboard.
Does Cuorips pay a dividend?
Cuorips does not currently show a material trailing dividend yield; it is positioned more as a total-return name. Always confirm the latest dividend policy in the company's filings.
Is Cuorips financially healthy?
Cuorips carries a debt-to-equity ratio of 0.00x and a current ratio of 15.93x, with a market beta of 0.86. Lower leverage and a current ratio above 1.0 generally signal a stronger balance sheet.
Is Cuorips a good stock to buy in 2026?
SniperIQ provides research-only market intelligence, not personalised financial advice or a buy/sell call. For Cuorips (4894) the key facts are: market cap ¥34.6B, revenue ¥212M, 52-week range 3610-12400. Weigh valuation, profitability, growth, and balance-sheet strength against Healthcare peers and form your own view.
Track Cuorips's full fundamentals live
Get Cuorips's 8-quarter revenue and margin trend, peer comparison, DCF model, and AI signal on the SniperIQ research dashboard.